Cognitive and motor functioning in gene carriers for Huntington's disease:: A baseline study

被引：44
|
作者：
Witjes-Ané, MNW
Vegter-van der Vlis, M
van Vugt, JPP
Lanser, JBK
Hermans, J
Zwinderman, AH
van Ommen, GJB
Roos, RAC
机构：
[1] Rijnland Hosp, Dept Neuropsychol, Liederdorp, Netherlands
[2] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands
来源：
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 2003年 / 15卷 / 01期
关键词：
ASYMPTOMATIC CARRIERS; RISK; IMPAIRMENT; DEMENTIA; MEMORY; MANIFESTATIONS; INDIVIDUALS; SYMPTOMS; PEOPLE; MARKER;
D O I：
10.1176/appi.neuropsych.15.1.7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The aim of this study was to investigate, the first changes in cognitive and motor functioning in Huntington's disease. Forty-six gene carriers, not clinically diagnosed for HD, were compared with 88 non-gene carriers. Gene carriers performed significantly worse on the Benton Visual Retention Test. This result was due to a minority of participants who had already developed cognitive impairment. Marginal differences appeared on the motor times of single reaction time measures after correction for motor signs. The findings are discussed in the context of inconsistencies in previous studies and underscore the need for longitudinal research.
引用
收藏
页码：7 / 16
页数：10
相关论文
共 50 条
  • [11] The Relationship Between Plasma Oxytocin and Executive Functioning in Huntington's Disease: A Pilot Study
    Fisher, Emily R.
    Rocha, Natalia P.
    Morales-Scheihing, Diego A.
    Venna, Venugopal Reddy
    Furr-Stimming, Erin E.
    Teixeira, Antonio L.
    Rossetti, Maria A.
    JOURNAL OF HUNTINGTONS DISEASE, 2021, 10 (03) : 349 - 354
  • [12] The role of APOE in cognitive trajectories and motor decline in Parkinson's disease
    Jo, Sungyang
    Kim, Seon-Ok
    Park, Kye Won
    Lee, Seung Hyun
    Hwang, Yun Su
    Chung, Sun Ju
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [13] Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
    Pavese, Nicola
    Politis, Marios
    Tai, Yen F.
    Barker, Roger A.
    Tabrizi, Sarah J.
    Mason, Sarah L.
    Brooks, David J.
    Piccini, Paola
    NEUROBIOLOGY OF DISEASE, 2010, 37 (02) : 356 - 361
  • [14] Determinants of Functional Disability in Huntington's Disease: Role of Cognitive and Motor Dysfunction
    Ross, Christopher A.
    Pantelyat, Alex
    Kogan, Jane
    Brandt, Jason
    MOVEMENT DISORDERS, 2014, 29 (11) : 1351 - 1358
  • [15] The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington's disease
    Bartlett, Danielle M.
    Govus, Andrew
    Rankin, Timothy
    Lampit, Amit
    Feindel, Kirk
    Poudel, Govinda
    Teo, Wei-Peng
    Lo, Johnny
    Georgiou-Karistianis, Nellie
    Ziman, Mel R.
    Cruickshank, Travis M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 416
  • [16] The Functional Implications of Motor, Cognitive, Psychiatric, and Social Problem-Solving States in Huntington's Disease
    Van Liew, Charles
    Gluhm, Shea
    Goldstein, Jody
    Cronan, Terry A.
    Corey-Bloom, Jody
    PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2013, 76 (04): : 323 - 335
  • [17] Cognitive function in men with non-motor features of Parkinson's disease
    Flores-Torres, Mario H.
    Hughes, Katherine C.
    Molsberry, Samantha
    Gao, Xiang
    Kang, Jae H.
    Schwarzschild, Michael A.
    Ascherio, Alberto
    BMJ NEUROLOGY OPEN, 2021, 3 (01)
  • [18] Associations between baseline cognitive status and motor outcomes after treadmill training in people with Parkinson's disease: a pilot study
    Amin, Raima M.
    Phillips, James J.
    Humbert, Andrew T.
    Cholerton, Brenna A.
    Short, Valerie D.
    Smith, Melissa J.
    Zabetian, Cyrus P.
    Mata, Ignacio F.
    Kelly, Valerie E.
    DISABILITY AND REHABILITATION, 2024, 46 (06) : 1082 - 1091
  • [19] Cognitive deterioration in Huntington's disease
    Redondo-Vergé, L
    REVISTA DE NEUROLOGIA, 2001, 32 (01) : 82 - 85
  • [20] Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutationA longitudinal follow–up study
    J. Lemiere
    M. Decruyenaere
    G. Evers-Kiebooms
    E. Vandenbussche
    R. Dom
    Journal of Neurology, 2004, 251 : 935 - 942
12345